Guidelines for Ulcerative Colitis Diagnosis and Management

UChicago Medicine

D. T. Rubin

How I Use JAK Inhibitors for IBD in My Practice

Scripps Health

E. Loftus

Debate: Stride II: Should We Treat to Target or Treat to Symptom Res…

EBMed

B. Abraham, A. Charabaty

Positioning Medical Therapy in IBD

Washington University in St. Louis

M. Ciorba

Use of Concomitant Medications in IBD-Evidence, Outcomes, and Risks

Boston University Chobanian & Avedisian School of Medicine

M. Kappelman

Positioning Therapies in IBD (audio only)

Asher Kornbluth

Precision Medicine in IBD

NYU Langone

M. Long

What’s New with the Old: Anti-TNFs and Anti-Integrins in IBD

Scripps Health

J. Sauk

Exit Strategy from Maintenance Therapy in IBD: When, Why, and If You…

Rubin Lab

D. T. Rubin

New and Emerging Therapies for Inflammatory Bowel Disease

University of Colorado Department of Medicine

W. Ahmed

Optimizing Current IBD Therapies

University of Colorado Department of Medicine

M. Long

Panel: Positioning of Therapies in IBD in 2024

Boston University Chobanian & Avedisian School of Medicine

L. Grossberg, M. Kappelman, G. Lichtenstein, M. Hamilton

Management of Pouchitis and Its Complications

MetroHealth

B. Shen

How I Optimize Biologic Therapies in IBD

Providence Swedish

T. L. Zisman

Goals of Treatment in IBD: Treatment Endpoints and Putting Risks int…

MedStar Georgetown and Northwestern University IBD Masterclass

C. Siegel

IL12/23 and IL23 Selective Inhibition in Inflammatory Bowel Disease

Gil Melmed

New and Emerging Treatments for IBD in 2024

University of Colorado Department of Medicine

M. Chiorean

Leukocyte Trafficking Agents in the Management of IBD

Washington University in St. Louis

K. Huff-Hardy

Positioning of Biologics and Small Molecules in Ulcerative Colitis

MetroHealth

M. Landsman

State of the Art Management of IBD: How Should We Sequence Therapies…

Rubin Lab

D. T. Rubin